menu search

Sale of walgreen's boots in flux in uk with less bidders, market upset

The multibillion-pound sale of U.K. drugstore Boots has been derailed after a possible buyer walked away and several bidders raised concerns about fin...

March 1, 2022, 11:50 pm

Sale of walgreen's boots in flux in uk with less bidders, market upset

The multibillion-pound sale of U.K. drugstore Boots has been derailed after a possible buyer walked away and several bidders raised concerns about fin...

March 1, 2022, 11:50 pm

5 short squeeze candidates to watch: kaival brands cost to borrow hits record 409%, blink charging and weber grills move up

Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily s...

February 28, 2022, 9:26 am

5 short squeeze candidates to watch: kaival brands cost to borrow hits record 409%, blink charging and weber grills move up

Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily s...

February 28, 2022, 9:26 am

5 short squeeze candidates to watch: kaival brands cost to borrow hits record 409%, blink charging and weber grills move up

Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily s...

February 28, 2022, 9:26 am

Ocugen's stock jumps 4% after saying fda lifted hold on trial for experimental covid-19 shot

Shares of Ocugen Inc. OCGN, -2.40% gained 4.7% in premarket trading on Friday after the company said the Food and Drug Administration lifted the clini...

February 25, 2022, 7:51 am

Ocugen's stock jumps 4% after saying fda lifted hold on trial for experimental covid-19 shot

Shares of Ocugen Inc. OCGN, -2.40% gained 4.7% in premarket trading on Friday after the company said the Food and Drug Administration lifted the clini...

February 25, 2022, 7:51 am

Ocugen's stock jumps 4% after saying fda lifted hold on trial for experimental covid-19 shot

Shares of Ocugen Inc. OCGN, -2.40% gained 4.7% in premarket trading on Friday after the company said the Food and Drug Administration lifted the clini...

February 25, 2022, 7:51 am

Relmada aces rel-1017 vs ketamine study for abuse potential

Relmada Therapeutics Inc (NASDAQ: RLMD) has announced topline results of the human abuse potential (HAP) study with REL-1017 for major depressive d...

February 23, 2022, 11:42 am

Relmada aces rel-1017 vs ketamine study for abuse potential

Relmada Therapeutics Inc (NASDAQ: RLMD) has announced topline results of the human abuse potential (HAP) study with REL-1017 for major depressive d...

February 23, 2022, 11:42 am

Relmada aces rel-1017 vs ketamine study for abuse potential

Relmada Therapeutics Inc (NASDAQ: RLMD) has announced topline results of the human abuse potential (HAP) study with REL-1017 for major depressive d...

February 23, 2022, 11:42 am

Pharmadrug announces positive results from dmt-analogue program to treat glaucoma

PharmaDrug Inc announced that it has successfully completed a head-to-head potency comparator study of its two undisclosed DMT-analogue ...

February 23, 2022, 9:10 am

Pharmadrug announces positive results from dmt-analogue program to treat glaucoma

PharmaDrug Inc announced that it has successfully completed a head-to-head potency comparator study of its two undisclosed DMT-analogue ...

February 23, 2022, 9:10 am

Pharmadrug announces positive results from dmt-analogue program to treat glaucoma

PharmaDrug Inc announced that it has successfully completed a head-to-head potency comparator study of its two undisclosed DMT-analogue ...

February 23, 2022, 9:10 am

Algernon pharmaceuticals begins manufacturing repirinast and launches new chronic kidney disease research program

Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) revealed that it has awarded a contract to China's Zhejiang Ausun Pharmaceutical Company Limited ...

February 23, 2022, 9:10 am

Algernon pharmaceuticals begins manufacturing repirinast and launches new chronic kidney disease research program

Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) revealed that it has awarded a contract to China's Zhejiang Ausun Pharmaceutical Company Limited ...

February 23, 2022, 9:10 am

Algernon pharmaceuticals begins manufacturing repirinast and launches new chronic kidney disease research program

Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) revealed that it has awarded a contract to China's Zhejiang Ausun Pharmaceutical Company Limited ...

February 23, 2022, 9:10 am

Okyo pharma receives us patent for dry eye disease drug covering neuropathic pain

OKYO Pharma Ltd said it has been issued a US patent for its dry eye disease candidate (DED) OK-101. Th...

February 23, 2022, 2:30 am

Okyo pharma receives us patent for dry eye disease drug covering neuropathic pain

OKYO Pharma Ltd said it has been issued a US patent for its dry eye disease candidate (DED) OK-101. Th...

February 23, 2022, 2:30 am

Okyo pharma receives us patent for dry eye disease drug covering neuropathic pain

OKYO Pharma Ltd said it has been issued a US patent for its dry eye disease candidate (DED) OK-101. Th...

February 23, 2022, 2:30 am


Search within

Pages Search Results: